Selected research
Industry Growth & Trends
Global Pharma-Grade Nitric Oxide Industry Growth and Trends Forecast to 2032
Market perspective
The global Pharma-Grade Nitric Oxide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pharma-Grade Nitric Oxide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pharma-Grade Nitric Oxide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharma-Grade Nitric Oxide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharma-Grade Nitric Oxide include Praxair, Novoteris, Inomax and Air Liquide, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pharma-Grade Nitric Oxide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pharma-Grade Nitric Oxide market size, estimates, and forecasts are presented in terms of sales volume (k m³) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharma-Grade Nitric Oxide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharma-Grade Nitric Oxide.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Pharma-Grade Nitric Oxide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pharma-Grade Nitric Oxide Market by Company
Praxair
Novoteris
Inomax
Air Liquide
Pharma-Grade Nitric Oxide Segment by Type
99.92% Purity
99.99% Purity
Pharma-Grade Nitric Oxide Segment by Application
Hospitals
Healthcare Centers
Others
Pharma-Grade Nitric Oxide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma-Grade Nitric Oxide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma-Grade Nitric Oxide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma-Grade Nitric Oxide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharma-Grade Nitric Oxide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pharma-Grade Nitric Oxide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 99.92% Purity
- 99.99% Purity
Applications
- Hospitals
- Healthcare Centers
- Others
Companies covered
- Praxair
- Novoteris
- Inomax
- Air Liquide
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Pharma-Grade Nitric Oxide Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Pharma-Grade Nitric Oxide Sales Estimates and Forecasts (2021-2032)
- 1.3 Pharma-Grade Nitric Oxide Market by Type
- 1.3.1 99.92% Purity
- 1.3.2 99.99% Purity
- 1.4 Global Pharma-Grade Nitric Oxide Market Size by Type
- 1.4.1 Global Pharma-Grade Nitric Oxide Market Size Overview by Type (2021-2032)
- 1.4.2 Global Pharma-Grade Nitric Oxide Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Pharma-Grade Nitric Oxide Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Pharma-Grade Nitric Oxide Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Pharma-Grade Nitric Oxide Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Pharma-Grade Nitric Oxide Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Pharma-Grade Nitric Oxide Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Pharma-Grade Nitric Oxide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Pharma-Grade Nitric Oxide Industry Trends
- 2.2 Pharma-Grade Nitric Oxide Industry Drivers
- 2.3 Pharma-Grade Nitric Oxide Industry Opportunities and Challenges
- 2.4 Pharma-Grade Nitric Oxide Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Pharma-Grade Nitric Oxide Revenue (2021-2026)
- 3.2 Global Top Players by Pharma-Grade Nitric Oxide Sales (2021-2026)
- 3.3 Global Top Players by Pharma-Grade Nitric Oxide Price (2021-2026)
- 3.4 Global Pharma-Grade Nitric Oxide Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pharma-Grade Nitric Oxide Major Company Production Sites & Headquarters
- 3.6 Global Pharma-Grade Nitric Oxide Company, Product Type & Application
- 3.7 Global Pharma-Grade Nitric Oxide Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pharma-Grade Nitric Oxide Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pharma-Grade Nitric Oxide Players Market Share by Revenue in 2025
- 3.8.3 2025 Pharma-Grade Nitric Oxide Tier 1, Tier 2, and Tier 3
4 Pharma-Grade Nitric Oxide Regional Status and Outlook
- 4.1 Global Pharma-Grade Nitric Oxide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Pharma-Grade Nitric Oxide Historic Market Size by Region
- 4.2.1 Global Pharma-Grade Nitric Oxide Sales in Volume by Region (2021-2026)
- 4.2.2 Global Pharma-Grade Nitric Oxide Sales in Value by Region (2021-2026)
- 4.2.3 Global Pharma-Grade Nitric Oxide Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Pharma-Grade Nitric Oxide Forecasted Market Size by Region
- 4.3.1 Global Pharma-Grade Nitric Oxide Sales in Volume by Region (2027-2032)
- 4.3.2 Global Pharma-Grade Nitric Oxide Sales in Value by Region (2027-2032)
- 4.3.3 Global Pharma-Grade Nitric Oxide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pharma-Grade Nitric Oxide by Application
- 5.1 Pharma-Grade Nitric Oxide Market by Application
- 5.1.1 Hospitals
- 5.1.2 Healthcare Centers
- 5.1.3 Others
- 5.2 Global Pharma-Grade Nitric Oxide Market Size by Application
- 5.2.1 Global Pharma-Grade Nitric Oxide Market Size Overview by Application (2021-2032)
- 5.2.2 Global Pharma-Grade Nitric Oxide Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Pharma-Grade Nitric Oxide Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Pharma-Grade Nitric Oxide Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Pharma-Grade Nitric Oxide Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Pharma-Grade Nitric Oxide Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Pharma-Grade Nitric Oxide Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Pharma-Grade Nitric Oxide Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Praxair
- 6.1.1 Praxair Company Information
- 6.1.2 Praxair Business Overview
- 6.1.3 Praxair Pharma-Grade Nitric Oxide Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Praxair Pharma-Grade Nitric Oxide Product Portfolio
- 6.1.5 Praxair Recent Developments
- 6.2 Novoteris
- 6.2.1 Novoteris Company Information
- 6.2.2 Novoteris Business Overview
- 6.2.3 Novoteris Pharma-Grade Nitric Oxide Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Novoteris Pharma-Grade Nitric Oxide Product Portfolio
- 6.2.5 Novoteris Recent Developments
- 6.3 Inomax
- 6.3.1 Inomax Company Information
- 6.3.2 Inomax Business Overview
- 6.3.3 Inomax Pharma-Grade Nitric Oxide Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Inomax Pharma-Grade Nitric Oxide Product Portfolio
- 6.3.5 Inomax Recent Developments
- 6.4 Air Liquide
- 6.4.1 Air Liquide Company Information
- 6.4.2 Air Liquide Business Overview
- 6.4.3 Air Liquide Pharma-Grade Nitric Oxide Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Air Liquide Pharma-Grade Nitric Oxide Product Portfolio
- 6.4.5 Air Liquide Recent Developments
7 North America by Country
- 7.1 North America Pharma-Grade Nitric Oxide Sales by Country
- 7.1.1 North America Pharma-Grade Nitric Oxide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Pharma-Grade Nitric Oxide Sales by Country (2021-2026)
- 7.1.3 North America Pharma-Grade Nitric Oxide Sales Forecast by Country (2027-2032)
- 7.2 North America Pharma-Grade Nitric Oxide Market Size by Country
- 7.2.1 North America Pharma-Grade Nitric Oxide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Pharma-Grade Nitric Oxide Market Size by Country (2021-2026)
- 7.2.3 North America Pharma-Grade Nitric Oxide Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Pharma-Grade Nitric Oxide Sales by Country
- 8.1.1 Europe Pharma-Grade Nitric Oxide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Pharma-Grade Nitric Oxide Sales by Country (2021-2026)
- 8.1.3 Europe Pharma-Grade Nitric Oxide Sales Forecast by Country (2027-2032)
- 8.2 Europe Pharma-Grade Nitric Oxide Market Size by Country
- 8.2.1 Europe Pharma-Grade Nitric Oxide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Pharma-Grade Nitric Oxide Market Size by Country (2021-2026)
- 8.2.3 Europe Pharma-Grade Nitric Oxide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Pharma-Grade Nitric Oxide Sales by Country
- 9.1.1 Asia-Pacific Pharma-Grade Nitric Oxide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Pharma-Grade Nitric Oxide Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Pharma-Grade Nitric Oxide Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Pharma-Grade Nitric Oxide Market Size by Country
- 9.2.1 Asia-Pacific Pharma-Grade Nitric Oxide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Pharma-Grade Nitric Oxide Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Pharma-Grade Nitric Oxide Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Pharma-Grade Nitric Oxide Sales by Country
- 10.1.1 South America Pharma-Grade Nitric Oxide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Pharma-Grade Nitric Oxide Sales by Country (2021-2026)
- 10.1.3 South America Pharma-Grade Nitric Oxide Sales Forecast by Country (2027-2032)
- 10.2 South America Pharma-Grade Nitric Oxide Market Size by Country
- 10.2.1 South America Pharma-Grade Nitric Oxide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Pharma-Grade Nitric Oxide Market Size by Country (2021-2026)
- 10.2.3 South America Pharma-Grade Nitric Oxide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Pharma-Grade Nitric Oxide Sales by Country
- 11.1.1 Middle East and Africa Pharma-Grade Nitric Oxide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Pharma-Grade Nitric Oxide Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Pharma-Grade Nitric Oxide Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Pharma-Grade Nitric Oxide Market Size by Country
- 11.2.1 Middle East and Africa Pharma-Grade Nitric Oxide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Pharma-Grade Nitric Oxide Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Pharma-Grade Nitric Oxide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Pharma-Grade Nitric Oxide Value Chain Analysis
- 12.1.1 Pharma-Grade Nitric Oxide Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Pharma-Grade Nitric Oxide Production Mode & Process
- 12.2 Pharma-Grade Nitric Oxide Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Pharma-Grade Nitric Oxide Distributors
- 12.2.3 Pharma-Grade Nitric Oxide Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst